Skip to content

[Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition)].

Unknown authors
Sep 2026 · Zhonghua zhong liu za zhi [Chinese journal of oncology] · Vol 48 9, pp. 1023-1059 · 0 citations
Medicine

TL;DR

The Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition) synthesizes the latest evidence-based medical advances in recent years covering lung cancer screening, diagnosis, pathology, genetic testing, immunologic and molecular biomarker testing, treatment modalities, and follow-up.

View source

Similar papers

[Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition)].

To further standardize the prevention and management of lung cancer in China, improve the level of diagnosis and treatment, enhance patient prognosis, and provide evidence-based professional recommendations for clinical practitioners at all levels, the Oncology Society of Chinese Medical Association organized experts f...

Unknown authors · 0 citations
Open access Nov 2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer.

The aim is to provide guidance for the optimisation and harmonisation of the management of patients with early and locally advanced NSCLC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials.

H. Hayashi, A. Zer, H. Kenmotsu et al. · 1 citation
Oct 2026

[Chinese guidelines for the diagnosis and management of chronic obstructive pulmonary disease (2026 revision)].

The Chinese guidelines for the diagnosis and management of chronic obstructive pulmonary disease (2026 revision) were developed by the Chronic Obstructive Pulmonary Disease Groups of the Chinese Thoracic Society and the Chinese Association of Chest Physicians and offers practical recommendations for the diagnosis and m...

Unknown authors · 0 citations
Open access Oct 2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

The aim is to provide guidance for the optimisation and harmonisation of the management of patients with RCC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials.

R. Kanesvaran, V. Gruenwald, A. Wong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.